- Home
- /
- Investors
- /
- Regulated Information
- /
- Share repurchase – Liquidity...
Share repurchase - liquidity agreement
DESCRIPTION OF THE SHARE REPURCHASE PROGRAM
DESCRIPTION OF THE SHARE REPURCHASE PROGRAM
AUTHORIZED BY THE SHAREHOLDERS' MEETING ON JUNE 10, 2021
The authorization given to the Board of Directors to implement a share repurchase program was approved by the Shareholders' Meeting on June 10, 2021 (8th resolution).
This authorization was given for a period of 18 months.
The maximum number of shares that may be repurchased under this authorization is set at 10% of the share capital.
Funding for the implementation of the share repurchase program is set at a maximum of 1,000,000 euros, unchanged from previous years.
The maximum unit price per share is set at 3 euros.
In previous years, this share repurchase program was used exclusively under a liquidity contract, in order to facilitate the liquidity of the Company's shares by an investment service provider.
REPORTS ON VALERIO THERAPEUTICS' LIQUIDITY CONTRACT
AMF REGULATED INFORMATION
